Nervgen Pharma Corp
(NGEN.VN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NGEN.VN | EPRX.TO | FRX.TO | ||
| Company | Nervgen Pharma Corp | Eupraxia Pharmaceuticals Inc | Fennec Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | TSX Venture | TSX | TSX | ||
| Open | 5.450 | 11.62 | 9.63 | ||
| High | 5.550 | 11.77 | 10.58 | ||
| Low | 5.300 | 11.40 | 9.63 | ||
| Latest | 5.350 | 11.58 | 10.58 | ||
| Change | unch | +0.12 | -0.21 | ||
| % Change | unch | +1.05% | -1.95% | ||
| Volume | 80,760 | 39,982 | 1,177 | ||
| 20-Day Average Volume | 107,204 | 83,793 | 957 | ||
| Previous Close | 5.350 | 11.46 | 10.79 | ||
| Industry | TSX Biotechnology | TSX Biotechnology | TSX Biotechnology | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 6.444 | 11.90 | 10.49 | ||
| 20-Day Raw Stochastic | 8.76% | 44.35% | 71.43% | ||
| 20-Day Relative Strength | 38.33 | 54.49 | 46.88 | ||
| Weighted Alpha | +37.20 | +152.09 | +4.21 | ||
| Today's Opinion | 40% Buy | 88% Buy | 56% Sell | ||
| Previous Opinion | 56% Buy | 88% Buy | 40% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.81% since 02/02/26 | +5.56% since 02/02/26 | +1.15% since 01/21/26 | ||
| Low | 5.210 on 02/05/26 | 10.81 on 02/03/26 | 9.63 on 02/09/26 | ||
| High | 5.860 on 02/03/26 | 12.41 on 02/03/26 | 10.79 on 02/05/26 | ||
| 1-Month | |||||
| %Chg | -32.62% since 01/09/26 | +2.84% since 01/09/26 | -2.49% since 01/09/26 | ||
| Low | 5.110 on 02/02/26 | 10.56 on 02/02/26 | 9.63 on 02/09/26 | ||
| High | 8.100 on 01/12/26 | 12.86 on 01/21/26 | 10.96 on 01/21/26 | ||
| 3-Month | |||||
| %Chg | +54.62% since 11/07/25 | +50.78% since 11/07/25 | -9.57% since 11/05/25 | ||
| Low | 3.240 on 11/18/25 | 7.70 on 11/10/25 | 9.63 on 02/09/26 | ||
| High | 8.490 on 01/08/26 | 12.86 on 01/21/26 | 12.50 on 11/18/25 | ||
| 6-Month | |||||
| %Chg | +75.99% since 08/08/25 | +60.61% since 08/08/25 | -7.19% since 08/08/25 | ||
| Low | 2.710 on 08/20/25 | 6.94 on 08/26/25 | 9.63 on 02/09/26 | ||
| High | 8.490 on 01/08/26 | 12.86 on 01/21/26 | 13.83 on 10/07/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 423,787 | 580,430 | 368,516 | ||
| Shares Outstanding, K | 79,213 | 50,648 | 34,153 | ||
| Annual Sales | 0 | 0 | 47,538,000 | ||
| Annual Net Income | -24,005,895 | -25,502,536 | -436,000 | ||
| Last Quarter Sales | 0 | 0 | 12,462,000 | ||
| Last Quarter Net Income | -4,156,070 | -6,361,367 | -638,000 | ||
| 60-Month Beta | 0.57 | 1.72 | 2.97 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 11/24/25 | -0.19 on 11/04/25 | -0.02 on 11/13/25 | ||
| Latest Earnings Date | N/A | N/A | 03/09/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | N/A | N/A | N/A | ||